The use of oral contraceptives (OC) is associated with an increased risk of thrombosis, suggesting OC exert procoagulant and/or antifibrinolytic effects. Given that physical exercise physiologically leads to an activation of blood coagulation and fibrinolysis, this study tested the hypothesis that OC might compromise the fibrinolytic response to exercise. Fibrinolytic variables were measured in 10 women (24 W 2 years) using OC (a formulation containing 30 mg ethinylestradiol and 150 mg desogestrel) and in 11 women without OC (mean W SD, 27 W 3 years) before, during and after a 1-h run on a treadmill at a velocity corresponding to an oxygen demand of 75-80% of maximum (anaerobic threshold). Exercise testing gave rise to considerable increases of tissue-type plasminogen activator antigen by seven-fold to eight-fold in women taking and not taking OC alike. In the presence of unchanged plasma levels of plasminogen activator inhibitor-1, exercise-induced release of tissue-type plasminogen activator led to enhanced plasmin formation with respect to plasmin-antiplasmin complexes, rising by (mean W standard error) 701 W 77 ng/ml (P < 0.001) in women using OC and by 695 W 117 ng/ml (P < 0.001 versus baseline; NS versus OC users) in controls. The fibrinolytic response to intensive physical exercise is preserved in women using OC and is similar to women not using OC.
Introduction
Epidemiologic data indicate that the use of oral contraceptives is associated with an increased risk of venous thrombosis, which is generally ascribed to the estrogenic activity in a dose-dependent manner [1, 2] . The results of the World Health Organization study [3] have provided strong evidence that third-generation oral contraceptives, containing low doses of estrogens and desogestrel or gestodene as progestogen, double the risk of venous thromboembolism compared with earlier formulations, implying that the progestogen component may have procoagulant and/or antifibrinolytic properties. Oral contraceptives have been demonstrated to induce several generally minor alterations of hemostatic and fibrinolytic variables at baseline: an increased activity of tissue-type plasminogen activator (t-PA) and a decrease of plasminogen activator inhibitor-1 (PAI-1) antigen and activity [4, 5] suggest profibrinolytic effects of oral contraceptives that may counteract the potentially procoagulant effects on fibrinogen, factor VII and factor X, the plasma levels of which are elevated in women using oral contraceptives [4, 6, 7] . Steady-state concentrations of fibrinolytic variables, however, do not necessarily reflect the fibrinolytic activity per se, since they depend in particular on the hepatic synthesis and clearance, which in turn is altered by estrogens [7] . It is not circulating levels of fibrinolytic variables, therefore, but rather the potential of endothelial cells to release t-PA that determines the capacity of endogenous fibrinolysis [8, 9] . Taking into consideration that physical exercise physiologically leads to an activation of fibrinolysis that is primarily attributed to the release of t-PA [10] , this study addressed the question of whether the fibrinolytic system responds adequately to physical exercise in women taking oral contraceptives.
Materials and methods

Participants
Ten women (mean AE SD age, 24 AE 2 years; body mass index, 20.7 AE 1.6 kg/m 2 ) using oral contraceptives in a formulation containing 30 mg ethinylestradiol and 150 mg desogestrel for at least 3 months and 11 controls without use of oral contraceptives (age, 27 AE 3 years; body mass index, 20.4 AE 2.0 kg/m 2 ) participated in the study. Individuals had no evidence of cardiovascular risk factors or thromboembolic disease in their personal or family history and received no further medication within the last 4 weeks before entering the study. Laboratory screening for thrombophilic risk factors identified one woman of the oral contraceptive group with a diminished response to activated protein C (APC) (APC ratio ¼ 2.0; APC resistance). Activities of protein C, protein S and antithrombin III were within normal ranges in all participants. The study protocol was approved by the ethical committee for human studies of the Medical Faculty at the University of Heidelberg. All participants gave their written informed consent before entering the study. Data on the exercise-induced activation of hemostasis in our study population have been recently published elsewhere [11] , demonstrating that the increase of markers of in-vivo thrombin and fibrin formation with exercise is more pronounced in women taking oral contraceptives versus women not taking oral contraceptives.
Exercise testing
Incremental graded exercise testing
To assess the individual treadmill speed at the anaerobic threshold, all individuals performed an incremental graded exercise test on a treadmill (slope, 1.5%) starting at an initial velocity of 8 km/h with increments of 2 km/h every 3 min until subjective exhaustion. Maximal oxygen consumption (VO 2max ) was measured by means of a metabolic cart (Oxycongamma; Mijnhardt b.v., Bunnik, The Netherlands) applying an open circuit method. The individual anaerobic threshold was determined according to the method of Stegmann et al. [12] and corresponded to 75-80% of VO 2max .
One-hour exercise tests
Two to five days after determination of VO 2max , individuals ran for 1 h on a treadmill at a velocity corresponding to the anaerobic threshold. This exercise model, a 1-h run at the anaerobic threshold, has been shown to induce significant formation of thrombin, fibrin and plasmin in several previous studies [13] [14] [15] . Exercise tests were performed between days 7 and 21 of drug intake in the oral contraceptives group and between days 18 and 22 of an ovulatory menstrual cycle according to daily measurements of basal body temperature in the control group. The luteal phase in controls was thereafter verified by determination of progesteron plasma levels, which revealed five women with an ovulatory cycle (progesteron > 10 ng/ml), three women with an anovulatory cycle (progesteron < 1 ng/ml) and three women in which ovulation was uncertain (1 ng/ml < progesteron < 10 ng/ml).
The heart rate was recorded continuously during the 1-h run by a sport tester (Polar Electro, Kempele, Finland), and plasma lactate was measured every 15 min during exercise to calculate a mean plasma lactate during exercise. All exercise tests started at the same time of day between 1400 and 1700 h. Characteristics of exercise testing are summarized in Table 1 .
Blood sampling and laboratory methods
Venous blood samples were collected at rest (0 min), after 30 min of exercise (30 min), and immediately after (60 min) as well as after 1 h of recovery (120 min). Apart from sampling during and immediately after exercise, all blood samples were drawn after participants had rested for 30 min in the supine position. To minimize artificial activation of blood coagulation in vitro, a venipuncture (20-gauge needle) was performed from an antecubital vein under controlled venous stasis of 45 Torr using the Sarstedt system (Sarstedt, Nü mbrecht, Germany).
Blood samples were collected in the following sequence. First, 9 ml blood was added to 1 ml of 0.106 mol/l trisodium citrate for determination of fibrinogen according to the method of Clauss, of the activated partial thromboplastin time (aPTT) with use of Pathromtin (Behring, Marburg, Germany), of the sensitivity to APC measured with the Coatest APC Resistance kit (Chromogenix AB, Mö lndal, Sweden) based on the prolongation of the aPTT after addition of APC (APC-ratio), of t-PA (TintElize tPA; Biopool, Umea, Sweden), of plasmin-antiplasmin complexes (PAP) (Enzygnost PAP; Behring), of D-dimer (Enzygnost D-Dimer micro; Behring) and of PAI-1 (TintElize PAI-1; Biopool). Second, 4.5 ml blood was added to 7.5 mg dry ethylenediamine tetraacetic acid for determination of the platelet count, hemoglobin level determination (Coulter Counter; Coulter Electronics, Krefeld, Germany) and for measurement of hematocrit (microhematocrit centrifuge; Hettich, Tuttlingen, Germany) in duplicate after 6 min of centrifugation at 13 000 Â g.
Immediately after blood sampling, tube 1 was rapidly put into melting crushed ice for 10 min and thereafter centrifuged at 48C for 30 min at 2000 Â g. Multiple aliquots of plasma were snap-frozen in liquid nitrogen and stored at À808C until analysis. Changes in plasma volume were calculated according to the method of Dill and Costill [16] . Coagulation parameters were corrected for changes of plasma volume occurring during exercise by the following factor: (100 þ DPV) / 100, where DPV is the change of plasma volume (percentage).
Statistical analysis
Anthropometric data and exercise characteristics were compared between women taking oral contraceptives and controls using Mann-Whitney U-tests. Since not Data presented as mean AE SD. Ã P < 0.05 for significant differences between groups (Mann-Whitney U-test).
all coagulation parameters were normally distributed, nonparametric analysis was used to test the main effects of exercise within each group (Friedman analysis of variance) and to investigate differences in hemostatic/fibrinolytic variables between groups before, during and after exercise as well as differences within the control group between those women with an ovulatory and those with an anovulatory menstrual cycle (Mann-Whitney U-test). The level of statistical significance was set at P values less than 0.05. Data are presented as the mean AE standard error unless otherwise stated.
Results
Both groups, users and nonusers of oral contraceptives, were well matched with respect to physical characteristics except for a slightly lower age range in women using oral contraceptives ( Table 1 ). The mean heart rate during exercise, mean plasma lactate concentrations and the decrease of plasma volume indicate that exercise intensity was comparable between the groups (Table 1) .
Hemostatic and fibrinolytic variables at rest
Within the control group, the coagulation parameters did not differ between individuals with an ovulatory (n ¼ 5) and individuals with an anovulatory menstrual cycle (n ¼ 6) either for baseline levels or for exercise-induced changes.
Plasma levels of fibrinogen at baseline were higher and the aPTT was shorter in women using oral contraceptives compared with controls (Table 2) . Furthermore, sensitivity to APC (APC ratio) was significantly lower in users of oral contraceptives than in nonusers; the values, however, were still within the range of normal with the exception of one women, in whom the APC ratio was 2.0 (APC resistance).
Plasma concentrations of PAI-1 were substantially lower in users of oral contraceptives than in nonusers, whereas t-PA-levels did not differ between groups (Table 2 and Fig. 1 ). Lower levels of t-PA and PAI-1 were associated with higher concentrations of PAP complexes in women taking oral contraceptives than in control women. Increased levels of D-dimers at rest reflect an enhanced degradation of fibrin in women using oral contraceptives as compared with controls.
Changes of fibrinolytic variables in response to exercise
Maximal running exercise for 1 h gave rise to considerable increases of t-PA by seven-fold to eight-fold in users and nonusers of oral contraceptives alike (Table 2 and Fig. 1 ). In the presence of essentially unchanged plasma levels of PAI-1, exercise-induced release of t-PA resulted in marked formation of plasmin with respect to increases of PAP complexes by two-fold to three-fold in both groups. Taken together, exercise-induced changes of t-PA, PAI-1 and of PAP did not differ between women taking and not taking oral contraceptives.
Likewise, although increases of D-dimers with exercise tended to be slightly higher in women using oral contraceptives as compared with controls, the difference between groups was statistically not significant (Table 2) .
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Discussion
The main finding of the present study is that the fibrinolytic response to exercise is not substantially affected by the use of third-generation oral contraceptives. Prolonged maximal exercise induced considerable increases in circulating plasma levels of t-PA and PAP in users and nonusers of oral contraceptives alike. Activation of plasmin formation during exercise resulted in enhanced degradation of fibrin with respect to plasma concentrations of D-dimers rising to a similar extent with exercise in both groups.
In women using oral contraceptives several alterations of hemostatic variables at baseline have been demonstrated, including an acceleration of prothrombin time and increases in plasma levels of factor VII, factor X and fibrinogen, which are related to both the dosage of estrogen as well as to the type and dosage of the progestogen component [6, 17, 18] . In accordance with these previous studies we found fibrinogen levels increased and the aPTT shortened in the oral contraceptives group. Furthermore, the APC ratio was diminished in women using oral contraceptives as compared with control individuals, although these changes did not exceed the range of normal except for one woman with an APC ratio of 2.0. The so-called acquired APC resistance in oral contraceptive users has also been shown by others [19, 20] .
Oral contraceptives affect fibrinolysis by increasing the activity of t-PA and consequently increasing the formation of plasmin as a result of reduced inhibition by PAI-1 [5, 21, 22] . The presented data confirm these findings with respect to higher baseline levels of PAP complexes in the presence of substantially lower plasma levels of PAI-1 in women using oral contraceptives compared with controls. In line with former studies [5, 23] , plasma levels of D-dimers at baseline were higher in women using oral contraceptives than in controls, indicating that the activation of plasmin formation leads to enhanced fibrin degradation. These apparently favorable effects on fibrinolytic parameters have led to the notion that oral contraceptives might even increase fibrinolytic activity [5] . It has to be considered, however, that oral contraceptives interfere with the synthesis and hepatic clearance of t-PA and PAI-1, and, consequently, the reported changes in circulating levels of fibrinolytic variables at baseline may not necessarily reflect an enhanced fibrinolytic activity per se [7, 24] . In the present study we have applied an exercise model in order to activate analyzed by nonparametric analysis of variance (Friedman). Ã P < 0.05, ÃÃ P < 0.01 for significant differences between groups (MannWhitney U-test).
fibrinolysis, addressing the question of whether the fibrinolytic systems in women taking oral contraceptives is capable of responding adequately to this physiological stimulus.
To our knowledge only a few data exist on exerciseinduced changes of fibrinolytic variables in women taking oral contraceptives. De Paz et al. [25] have reported that the fibrinolytic response to short maximal exercise (< 12 min) is not altered by use of oral contraceptives with respect to exercise-induced increases of t-PA activity and fibrin degradation products, which did not differ between women using and not using oral contraceptives [25] . In a recent study, Hoetzer et al. [26] have investigated the endothelial release of t-PA in an isolated forearm model in premenopausal women taking oral contraceptives. The main result of this study was that the basal and (bradykinin, sodium nitroprusside-)stimulated release of t-PA was not affected by oral contraceptive use. Our findings are consistent with these studies, since exercise-induced changes of t-PA, PAP and of D-dimers in women using oral contraceptives paralleled those observed in controls, although concentrations of PAP complexes and D-dimers in women using oral contraceptives started from higher levels at baseline. Taken together, our data clearly indicate that the fibrinolytic response to exercise is not influenced (or compromised) by the use of oral contraceptives.
It is noteworthy that plasma levels of t-PA and PAP complexes rapidly declined after exercise while D-dimers continued to increase also in the recovery period. This divergence may in part be explained by substantial differences in half-life times, which are in the order of 3-5 min for t-PA and 90 min for PAP complexes but account for several hours for D-dimers [27] . Nevertheless, the prolonged increase of D-dimers indicates ongoing fibrin degradation even 1 h after exercise testing.
We have recently reported the exercise-induced activation of the hemostatic system in our study population, highlighting that the formation of thrombin and fibrin with exercise is greatly enhanced in women using oral contraceptives compared with controls [11] . In perspective of these findings, an increased hemostatic activation with exercise on the one hand and a preserved fibrinolytic activation on the other hand, gives rise to the question of whether activation of coagulation and fibrinolysis with exercise is still a balanced process in women taking oral contraceptives. This suspected imbalance, indeed, might be relevant for the increased risk of thrombosis associated with the use of oral contraceptives.
In summary, third-generation oral contraceptives apparently do not affect the fibrinolytic response to exercise, in particular the endothelial release of t-PA, either positively or negatively. These findings question the conception that enhanced coagulability under oral contraceptive use is counterbalanced by an increased fibrinolytic capacity.
